NCT04984213已完成不适用
CORTI-FIX: Clinical and Radiographic Outcomes Following Lumbar Interbody Placement With Posterior Minimally Invasive Intra-Laminar PEEK Ratcheting Fixation Device
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Fusion Rate
研究概览
简要总结
The primary objective of this clinical study is to measure fusion rate in patients at 12 months following lumbar fusion in combination with posterior fixation using the Karma® device.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Skeletally mature and age ≥ 18 years of age
- •Appropriate patient as determined by the Investigator for anterior or lateral approach to lumbar interbody fusion surgery with planned posterior fixation to treat degenerative disc disease in one or two adjacent vertebral levels between L2 and S
- •Failed at least six months of conservative treatment. This may or may not include any of the following,
- •Spinal injections
- •Chiropractic care
- •Physical therapy
- •Activity modification and/or with anti-inflammatory medications
- •Oswestry Low Back Pain Disability Questionnaire score of at least 30%
- •Visual Analog Scale (VAS) for back/hip/lower extremity pain ranking at a minimum at least 3/10 (30%)
- •Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule, study requirements with a signed informed consent with a study collaborator present at the time of signing to ensure compliance.
排除标准
- •Patients with greater than two levels of degenerative disease or deformity for INTENDED operative levels.
- •Previous fusion or total disc replacement at the intended level/s
- •Known allergy to implant and instrument materials
- •Clinically compromised vertebral bodies at the affected level(s) due to current or past trauma
- •Degenerative spondylolisthesis of grade >2
- •Isthmic spondylolisthesis
- •Back or leg pain of unknown etiology
- •Active systemic infection or infection at the location planned surgery
- •Active or suspected malignancy. If symptom free for 2 years, patients with prior malignancy may be included.
- •Morbid obesity defined as a body mass index > 40
- •Patient being treated for other specific medical conditions that may affect bone density or the ability to obtain fusion (ie: steroids, etc)
- •Pregnant or have plans to become pregnant in the next year.
- •Currently a prisoner
- •Patient has any condition, that in the opinion of the Investigator, would prohibit the patient from complying with the protocol
- •Participation in a concurrent clinical study.
结局指标
主要结局
Fusion Rate
时间窗: 12 months
Interbody Fusion Rate
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium CageIntervertebral Disc DiseaseNCT03018392Bone and Joint Clinic of Baton Rouge20
终止
2 期
Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone MarrowDegenerative OsteoarthritisDegenerative Lumbar VertebraNCT01335243University Hospital, Bordeaux32
终止
不适用
Prospective Study of Fusion Rates Using Spira-C Device for Anterior Cervical Discectomy and Fusion SurgeryCervical RadiculopathyCervical Disc DiseaseNCT03786432William Beaumont Hospitals13
终止
不适用
PEMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff TearsFull-thickness Rotator Cuff TearNCT03339492Orthofix Inc.377
已完成
不适用
Fusion Assessment Clinical TrialDegenerative Disc DiseaseNCT00736398Flexuspine, Inc.50